DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹5,674 Cr | ₹4,643 Cr | ₹4,543 Cr | ₹5,888 Cr | ₹2,811 Cr |
What is the latest Cash Flow from Operating Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹5,674 Cr |
| Mar2025 | ₹4,643 Cr |
| Mar2024 | ₹4,543 Cr |
| Mar2023 | ₹5,888 Cr |
| Mar2022 | ₹2,811 Cr |
How is Cash Flow from Operating Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,674 Cr | 22.20 | |
| Mar2025 | ₹4,643 Cr | 2.19 | |
| Mar2024 | ₹4,543 Cr | -22.83 | |
| Mar2023 | ₹5,888 Cr | 109.46 | |
| Mar2022 | ₹2,811 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹96,207.5 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,472.0 Cr | -2.4% | 1.2% | -3.2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -5.8% |
-13.2% |
-7.7% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses